Epstein–Barr virus (EBV) is an obligatory factor in the development of nasopharyngeal carcinoma (NPC), and anti-EBV IgA antibodies are elevated many years prior to the development of NPC. Nearly all adults are infected with EBV, but only a few develop cancer, suggesting that additional co-factors, including genetic susceptibility, must be required for the disease to manifest. Individuals were selected from the Taiwan Family Study, a cohort of 3389 individuals from NPC multiplex families. Primary analyses were conducted among 671 individuals from 69 pedigrees with the strongest family history of disease (>3 NPC-affected family members). The likelihood that a given family member carried a NPC susceptibility variant was estimated using Mendelian segregation rules, assuming a dominant mode of inheritance. We compared anti-EBV IgA antibody seropositivity between family members predicted to be carriers of NPC-linked genetic variants and those with a lower likelihood of carrying such variants. Obligate carriers of NPC susceptibility variants (100 % predicted probability of harbouring the genetic mutation) were nine-fold more likely to be anti-EBV IgA positive compared to family members predicted not to carry disease-causing variants (OR=9.2; P-trend<0.001). This elevated risk was confirmed in analyses restricted to both unaffected individuals and pedigrees with EBV-related pathway variants identified through exome sequencing. Our data indicate that family members who are more likely to carry NPC susceptibility variants are also more likely to be anti-EBNA1 IgA seropositive. Genetic susceptibility associated with control over this common herpes virus is likely a co-factor in determining which EBV-infected adults develop NPC.
Zur HausenH, Schulte-HolthausenH, KleinG, HenleW, HenleG et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature1970; 228:1056–1058[PubMed]
HenleW, HenleG, HoHC, BurtinP, CachinY et al. Antibodies to Epstein–Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst1970; 44:225–231[PubMed]
BorzaCM, Hutt-FletcherLM. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med2002; 8:594–599 [View Article][PubMed]
CaoSM, LiuZ, JiaWH, HuangQH, LiuQ et al. Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PLoS One2011; 6:e19100 [View Article][PubMed]
HenleG, HenleW. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer1976; 17:1–7 [View Article][PubMed]
BeiJX, SuWH, NgCC, YuK, ChinYM et al. A GWAS meta-analysis and replication study identifies a novel locus within CLPTM1L/TERT associated with nasopharyngeal carcinoma in individuals of chinese ancestry. Cancer Epidemiol Biomarkers Prev2016; 25:188–192 [View Article][PubMed]
SuWH, HildesheimA, ChangYS. Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers. Front Oncol2013; 3:299 [View Article][PubMed]
TangM, LautenbergerJA, GaoX, SezginE, HendricksonSL et al. The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet2012; 8:e1003103 [View Article][PubMed]
TseKP, SuWH, ChangKP, TsangNM, YuCJ et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet2009; 85:194–203 [View Article][PubMed]
HuLF, QiuQH, FuSM, SunD, MagnussonK et al. A genome-wide scan suggests a susceptibility locus on 5p 13 for nasopharyngeal carcinoma. Eur J Hum Genet2008; 16:343–349 [View Article][PubMed]
XiongW, ZengZY, XiaJH, XiaK, ShenSR et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res2004; 64:1972–1974 [View Article][PubMed]
YuKJ, HsuWL, PfeifferRM, ChiangCJ, WangCP et al. Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families. Clin Cancer Res2011; 17:1906–1914 [View Article][PubMed]
YuKJ, GaoX, ChenCJ, YangXR, DiehlSR et al. Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol2009; 70:910–914 [View Article][PubMed]